These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 6352937)
1. Antibodies to cytoplasmic intermediate filaments in rheumatic diseases. Kurki P; Helve T; Virtanen I J Rheumatol; 1983 Aug; 10(4):558-62. PubMed ID: 6352937 [TBL] [Abstract][Full Text] [Related]
2. [Significance of antibodies against intermediate filaments in rheumatoid polyarthritis, chronic inflammatory rheumatism and connective tissue diseases]. Fabregas-Canales D; Meyer O; Haim T; Kuntz D Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):45-50. PubMed ID: 2471252 [No Abstract] [Full Text] [Related]
3. Idiotypic analysis of a B cell clone with anti-intermediate filament specificity in a patient with Sjögren's syndrome: involvement of five subpopulations producing different immunoglobulin isotypes. Landay A; Kubagawa H; Cooper MD J Immunol; 1986 Jul; 137(1):129-36. PubMed ID: 3086445 [TBL] [Abstract][Full Text] [Related]
4. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus. Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442 [TBL] [Abstract][Full Text] [Related]
5. [Humoral reactivity against the secretory component of secretory IgA in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus]. Luft S; Brzezińska B; Wójcik-Scisłowska M; Małdykowa H; Pazdur J; Strauss MM Reumatologia; 1979; 17(2):137-43. PubMed ID: 472524 [No Abstract] [Full Text] [Related]
6. Antibodies to vimentin intermediate filaments in sera from patients with SLE and RA: quantitation by solid phase radioimmunoassay. Alcover A; Ramirez-Lafita F; Hernandez C; Nieto A; Avila J J Rheumatol; 1985 Apr; 12(2):233-6. PubMed ID: 3897530 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome. Szántó A; Csípo I; Zeher M J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756 [No Abstract] [Full Text] [Related]
8. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease. Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526 [TBL] [Abstract][Full Text] [Related]
9. Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA. Ruffatti A; Ostuni P; Grypiotis P; Botsios C; Tonello M; Grava C; Favaro M; Todesco S J Rheumatol; 2004 Mar; 31(3):504-7. PubMed ID: 14994395 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases. Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202 [TBL] [Abstract][Full Text] [Related]
11. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism. Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus. Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237 [TBL] [Abstract][Full Text] [Related]
13. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus]. Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505 [TBL] [Abstract][Full Text] [Related]
14. Anticytoskeletal autoantibody development in adjuvant arthritis. Franch A; Castellote C; Vilà JL; Vilaró S; Castell M J Rheumatol; 1994 Mar; 21(3):489-97. PubMed ID: 7516431 [TBL] [Abstract][Full Text] [Related]
15. Clinical and serological heterogeneity in patients with anticentromere antibodies. Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324 [TBL] [Abstract][Full Text] [Related]
16. IgG subclasses of anti-tetanus toxoid antibodies in adult and newborn normal subjects and in patients with systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. Rubin RL; Tang FL; Lucas AH; Spiegelberg HL; Tan EM J Immunol; 1986 Oct; 137(8):2522-7. PubMed ID: 3760565 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to nucleic acids in human and murine lupus. Talal N J Rheumatol; 1975 Jun; 2(2):130-4. PubMed ID: 125343 [TBL] [Abstract][Full Text] [Related]
18. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases. Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977 [TBL] [Abstract][Full Text] [Related]
19. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. Moutsopoulos HM; Steinberg AD; Fauci AS; Lane HC; Papadopoulos NM J Immunol; 1983 Jun; 130(6):2663-5. PubMed ID: 6406594 [TBL] [Abstract][Full Text] [Related]
20. Neurofilament antibodies in systemic lupus erythematosus. Kurki P; Helve T; Dahl D; Virtanen I J Rheumatol; 1986 Feb; 13(1):69-73. PubMed ID: 3517324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]